The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Cancer and the gut microbiota: An unexpected link
Open accessAbstract
Gut microbiota and its interactions with the host immune system play a role in oncogenesis and can alter the effectiveness of anticancer agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among all tumors, GC is arguably the most intensely affected by gut bacteria owing to their spatial proximity, and their associations with the gut microbiome have been intensively investigated [93,94].”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [93]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Role of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., et al. (2013) · Science · doi:10.1126/science.1240527 · Cited by 2,251
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., et al. (2013) · Science · doi:10.1126/science.1240537 · Cited by 2,050
Self-citationSchwabe, R. F., & Jobin, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3610 · Cited by 1,689
Reciprocal interactions of the intestinal microbiota and immune system
Maynard, C. L., Elson, C. O., Hatton, R. D., & Weaver, C. T. (2012) · Nature · doi:10.1038/nature11551 · Cited by 1,598 · cited 2×
“A detailed description of the intestinal immune system is beyond the scope of this article and can be found in (2).”
BackgroundPromotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., et al. (2010) · Science · doi:10.1126/science.1191175 · Cited by 1,080
Cited by
Sorted by citations
Dendritic cells in cancer immunology and immunotherapy
Wculek, S. K., Cueto, F. J., Mujal, A. M., Melero, I., Krummel, M. F., & Sancho, D. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0210-z · Cited by 2,688
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.008 · Cited by 2,198
Gut Bacteroides species in health and disease
Zafar, H., & Saier, M. H. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1848158 · Cited by 1,303
Pitt, J. M., Vétizou, M., Daillère, R., Roberti, M. P., Yamazaki, T., Routy, B., Lepage, P., Boneca, I. G., Chamaillard, M., Kroemer, G., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.001 · Cited by 1,060
Self-citationDaillère, R., Vétizou, M., Waldschmitt, N., Yamazaki, T., Isnard, C., Poirier-Colame, V., Duong, C. P. M., Flament, C., Lepage, P., Roberti, M. P., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.009 · Cited by 897
Self-citationPalucka, A. K., & Coussens, L. M. (2016) · Cell · doi:10.1016/j.cell.2016.01.049 · Cited by 843
Mechanisms and consequences of intestinal dysbiosis
Weiss, G. A., & Hennet, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2509-x · Cited by 775
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma
Mima, K., Sukawa, Y., Nishihara, R., Qian, Z. R., Yamauchi, M., Inamura, K., Kim, S. A., Masuda, A., Nowak, J. A., Nosho, K., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1377 · Cited by 669
The hallmarks of successful anticancer immunotherapy
Galluzzi, L., Chan, T. A., Kroemer, G., Wolchok, J. D., & López-Soto, A. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat7807 · Cited by 575
Self-citationButyrate-producing human gut symbiont, Clostridium butyricum , and its role in health and disease
Stoeva, M. K., Garcia-So, J., Justice, N., Myers, J. N., Tyagi, S., Nemchek, M. P., McMurdie, P. J., Kolterman, O., & Eid, J. S. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1907272 · Cited by 546
Targeting T Cell Co-receptors for Cancer Therapy
Callahan, M. K., Postow, M. A., & Wolchok, J. D. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.023 · Cited by 480
Thomas, S., Izard, J., Walsh, E. K., Batich, K. A., Chongsathidkiet, P., Clarke, G. A., Sela, D. A., Muller, A. J., Mullin, J. M., Albert, K., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2929 · Cited by 400
Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment
Zhao, Z., & Liu, W. C. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820962117 · Cited by 377
Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota
Xu, J., Chen, H., & Li, S. (2017) · Medicinal Research Reviews · doi:10.1002/med.21431 · Cited by 346
Honey bees as models for gut microbiota research
Zheng, H., Steele, M. I., Leonard, S. P., Motta, E. V. S., & Moran, N. A. (2018) · Lab Animal · doi:10.1038/s41684-018-0173-x · Cited by 348
Dietary polyphenol impact on gut health and microbiota
Wan, M. L. Y., Co, V. A., & El-Nezami, H. S. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1744512 · Cited by 340
Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation
Peled, J. U., Devlin, S. M., Staffas, A., Lumish, M., Khanin, R., Littmann, E. R., Ling, L., Kosuri, S., Maloy, M., Slingerland, J. B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.3348 · Cited by 325
The mutual interplay of gut microbiota, diet and human disease
Illiano, P., Brambilla, R., & Parolini, C. (2020) · FEBS Journal · doi:10.1111/febs.15217 · Cited by 338
Natural and therapy-induced immunosurveillance in breast cancer
Kroemer, G., Senovilla, L., Galluzzi, L., André, F., & Zitvogel, L. (2015) · Nature Medicine · doi:10.1038/nm.3944 · Cited by 316
Self-citationROS-modulated therapeutic approaches in cancer treatment
Raza, M. H., Siraj, S., Arshad, A., Waheed, U., Aldakheel, F. M., Alduraywish, S. A., & Arshad, M. M. U. D. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2464-9 · Cited by 304
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
Panebianco, C., Andriulli, A., & Pazienza, V. (2018) · Microbiome · doi:10.1186/s40168-018-0483-7 · Cited by 351
TH17 cell heterogeneity and its role in tissue inflammation
Schnell, A., Littman, D. R., & Kuchroo, V. K. (2023) · Nature Immunology · doi:10.1038/s41590-022-01387-9 · Cited by 286
Chen, F., Dai, X., Zhou, C., Li, K.-X., Zhang, Y., Lou, X., Zhu, Y., Sun, Y., Peng, B.-X., & Cui, W. (2021) · Gut · doi:10.1136/gutjnl-2020-323476 · Cited by 295
Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location
Mima, K., Cao, Y., Chan, A. T., Qian, Z. R., Nowak, J. A., Masugi, Y., Shi, Y., Song, M., da Silva, A., Gu, M., et al. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.53 · Cited by 284
Dong, X., Pan, P., Zheng, D., Bao, P., Zeng, X., & Zhang, X. (2020) · Science Advances · doi:10.1126/sciadv.aba1590 · Cited by 282
Oliva, M., Spreafico, A., Taberna, M., Alemany, L., Coburn, B. A., Mesı́a, R., & Siu, L. L. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy507 · Cited by 265
Gut microbiome and cancer immunotherapy
Li, W., Deng, Y., Chu, Q., & Zhang, P. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.015 · Cited by 262
Ponzetta, A., Carriero, R., Carnevale, S., Barbagallo, M., Molgora, M., Perucchini, C., Magrini, E. I., Gianni, F., Kunderfranco, P., Polentarutti, N., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.047 · Cited by 258
The Microbiome of the Prostate Tumor Microenvironment
Cavarretta, I. T. R., Ferrarese, R., Cazzaniga, W., Saita, D., Lucianò, R., Ceresola, E. R., Locatelli, I., Visconti, L. M., Lavorgna, G., Briganti, A., et al. (2017) · European Urology · doi:10.1016/j.eururo.2017.03.029 · Cited by 251
The Development and Evaluation of a Literature-Based Dietary Index for Gut Microbiota
Kase, B. E., Liese, A. D., Zhang, J., Murphy, E. A., Zhao, L., & Steck, S. E. (2024) · Nutrients · doi:10.3390/nu16071045 · Cited by 221
Yang, L., Li, A., Lei, Q., & Zhang, Y. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0804-8 · Cited by 215
Tosolini, M., Pont, F., Poupot, M., Vergez, F., Nicolau-Travers, M.-L., Vermijlen, D., Sarry, J., Dieli, F., & Fournié, J. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1284723 · Cited by 197
Galloway-Peña, J., Smith, D. P., Sahasrabhojane, P. V., Ajami, N. J., Wadsworth, W. D., Daver, N. G., Chemaly, R. F., Marsh, L., Ghantoji, S. S., Pemmaraju, N., et al. (2016) · Cancer · doi:10.1002/cncr.30039 · Cited by 192
von Martels, J. Z. H., Sadabad, M. S., Bourgonje, A. R., Blokzijl, T., Dijkstra, G. D. H., Faber, K. N., & Harmsen, H. J. M. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.01.001 · Cited by 186
Immunogenic cell death in cancer: concept and therapeutic implications
Galluzzi, L., Kepp, O., Hett, E. C., Kroemer, G., & Marincola, F. M. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04017-6 · Cited by 200
Self-citationNeutrophils in the tumor microenvironment: trying to heal the wound that cannot heal
Singel, K. L., & Segal, B. H. (2016) · Immunological Reviews · doi:10.1111/imr.12459 · Cited by 185
Kim, M., Vogtmann, E., Ahlquist, D. A., Devens, M. E., Kisiel, J. B., Taylor, W. R., White, B. A., Hale, V. L., Sung, J., Chia, N., et al. (2020) · mBio · doi:10.1128/mbio.03186-19 · Cited by 179
Gut microbiome modulates efficacy of immune checkpoint inhibitors
Yi, M., Yu, S., Qin, S., Liu, Q., Xu, H., Zhao, W., Chu, Q., & Wu, K. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0592-6 · Cited by 179
Keep calm: the intestinal barrier at the interface of peace and war
Thoo, L., Noti, M., & Krebs, P. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2086-z · Cited by 168
Dietary Fat and Cancer—Which Is Good, Which Is Bad, and the Body of Evidence
Bojková, B., Winklewski, P. J., & Wszędybył-Winklewska, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114114 · Cited by 166
Namasivayam, S., Maïga, M., Yuan, W., Thovarai, V., Costa, D. L., Mittereder, L. R., Wipperman, M. F., Glickman, M. S., Dzutsev, A., Trinchieri, G., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0286-2 · Cited by 162
Sokołowska, M., Frei, R., Lunjani, N., Akdiş, C. A., & O’Mahony, L. (2018) · Asthma Research and Practice · doi:10.1186/s40733-017-0037-y · Cited by 152
Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer
Mileo, A. M., Nisticò, P., & Miccadei, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00729 · Cited by 157
Engineering probiotics as living diagnostics and therapeutics for improving human health
Zhou, Z., Chen, X., Sheng, H., Shen, X., Sun, X., Yan, Y., Wang, J., & Yuan, Q. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-01318-z · Cited by 153
Tumor-intrinsic oncogene pathways mediating immune avoidance
Spranger, S., & Gajewski, T. F. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1086862 · Cited by 154
Sex Hormones and Anticancer Immunity
Özdemir, B. C., & Dotto, G. P. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0137 · Cited by 134
Gut microbiota regulate tumor metastasis via circRNA/miRNA networks
Zhu, Z., Huang, J., Li, X., Xing, J. Q., Chen, Q., Liu, R., Hua, F., Qiu, Z., Song, Y., Bai, C., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1788891 · Cited by 134
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications
Buqué, A., Bloy, N., Aranda, F., Castoldi, F., Eggermont, A. M. M., Cremer, I., Fridman, W. H., Fucikova, J. P., Galon, J., Marabelle, A., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1008814 · Cited by 132
Self-citationNeuzillet, C., Marchais, M., Vacher, S., Hilmi, M., Schnitzler, A., Meseure, D., Leclère, R., Lecerf, C., Dubot, C., Jeannot, E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86816-9 · Cited by 128
Mukherjee, S., Joardar, N., Sengupta, S., & Babu, S. P. S. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.07.010 · Cited by 129
Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-cancer Therapy
Wegiel, B., Vuerich, M., Daneshmandi, S., & Seth, P. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00284 · Cited by 129
Microbiota in cancer development and treatment
Raza, M. H., Gul, K., Arshad, A., Riaz, N., Waheed, U., Rauf, A., Aldakheel, F. M., Alduraywish, S. A., Rehman, M. U., Abdullah, M., et al. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2816-0 · Cited by 122
Antibiotic therapy and outcome from immune-checkpoint inhibitors
Pinato, D. J., Gramenitskaya, D., Altmann, D. M., Boyton, R. J., Mullish, B. H., Marchesi, J. R., & Bower, M. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0775-x · Cited by 116
Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
Shui, L., Yang, X., Li, J., Yi, C., Sun, Q., & Zhu, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02989 · Cited by 115
An overview of cancer health disparities: new approaches and insights and why they matter
Minas, T. Z., Bailey‐Whyte, M., Ajao, A., & Ambs, S. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa121 · Cited by 119
Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
Li, S., Liu, J., Zheng, X., Ren, L., Yang, Y., Li, W., Fu, W., Wang, J., & Du, G. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0651 · Cited by 116
Ševčíková, A., Izoldova, N., Števurková, V., Kasperova, B., Chovanec, M., Čierniková, S., & Mego, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010488 · Cited by 109
INTESTINAL MICROBIOTA IN DIGESTIVE DISEASES
Passos, M. D. C. F., & Moraes-Filho, J. P. P. (2017) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.201700000-31 · Cited by 125
Structure and Function of CutC Choline Lyase from Human Microbiota Bacterium Klebsiella pneumoniae
Kalnins, G., Kuka, J., Grı̄nberga, S., Makrecka‐Kuka, M., Liepinsh, E., Dambrova, M., & Tārs, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.670471 · Cited by 106
From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation
Bajic, J. E., Johnston, I. N., Howarth, G. S., & Hutchinson, M. R. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00104 · Cited by 100
Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy
Verdura, S., Cuyàs, E., Martı́n-Castillo, B., & Menéndez, J. A. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1633235 · Cited by 99
Bobin-Dubigeon, C., Luu, H. T., Leuillet, S., Lavergne, S. N., Carton, T., Le Vacon, F., Michel, C., Nazih, H., & Bard, J.-M. (2021) · Nutrients · doi:10.3390/nu13082705 · Cited by 90
Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics
Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97
Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice
Panebianco, C., Adamberg, K., Jaagura, M., Copetti, M., Fontana, A., Adamberg, S., Kolk, K., Vilu, R., Andriulli, A., & Pazienza, V. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3549-0 · Cited by 97
Hypoxia-Induced Resistance to Chemotherapy in Cancer
Minassian, L. M., Cotechini, T., Huitema, E., & Graham, C. H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_9 · Cited by 102
Constituents, Pharmacokinetics, and Pharmacology of Gegen-Qinlian Decoction
Lu, J., Ye, D., & Ma, B. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.668418 · Cited by 100
Chen, L., Zhou, X., Wang, Y., Wang, D., Ke, Y., & Zeng, X. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100096 · Cited by 94
The impact of the intestinal microbiota in therapeutic responses against cancer
Goubet, A., Daillère, R., Routy, B., Derosa, L., Roberti, P. M., & Zitvogel, L. (2018) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2018.03.004 · Cited by 94
Self-citationWeber, D., Hiergeist, A., Weber, M., Dettmer, K., Wolff, D., Hahn, J., Herr, W., Gessner, A., & Holler, E. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy711 · Cited by 92
The Microbiome and Tuberculosis: Early Evidence for Cross Talk
Namasivayam, S., Sher, A., Glickman, M. S., & Wipperman, M. F. (2018) · mBio · doi:10.1128/mbio.01420-18 · Cited by 97
Dubey, S. R., Turnbull, C., Pandey, A., Zhao, A., Kurera, M., Al-Zidan, R. N., Shen, C. X., Gautam, M., Mahajan, S., Jadhav, P. S., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01354-y · Cited by 101
Sommer, F., & Bäckhed, F. (2016) · BioEssays · doi:10.1002/bies.201500151 · Cited by 96
Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment
Pouncey, A. L., Scott, A. J., Alexander, J. L., Marchesi, J. R., & Kinross, J. K. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.868 · Cited by 89
A cell atlas of microbe-responsive processes in the zebrafish intestine
Willms, R. J., Jones, L. O., Hocking, J. C., & Foley, E. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110311 · Cited by 87
Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis
Jiang, J., Chen, X., Ren, Z., & Zheng, S. (2018) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2018.11.002 · Cited by 100
Lankes, K., Hundorfean, G., Harrer, T., Pommer, A. J., Agaimy, A., Angelovska, I., Tajmir-Riahi, A., Göhl, J., Schuler, G., Neurath, M. F., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1128611 · Cited by 85
The Binding Efficiency and Interaction of Lactobacillus casei Shirota Toward Aflatoxin B1
Liew, W.-P.-P., Adilah, Z. N., Than, L. T. L., & Sabran, M. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01503 · Cited by 85
The stem cell division theory of cancer
López‐Lázaro, M. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.01.010 · Cited by 91
Matsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83
“Among all tumors, GC is arguably the most intensely affected by gut bacteria owing to their spatial proximity, and their associations with the gut microbiome have been intensively investigated [93,94].”
BackgroundThe microbiome in chronic kidney disease patients undergoing hemodialysis and peritoneal dialysis
Simões‐Silva, L., Araújo, R., Pestana, M., Soares‐Silva, I., & Sampaio‐Maia, B. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.011 · Cited by 87
Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth
McKee, A. M., Kirkup, B. M., Madgwick, M., Fowler, W. J., Price, C. A., Dreger, S. A., Ansorge, R., Makin, K. A., Caim, S., Le Gall, G., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103012 · Cited by 81
Health-Improving Effects of Polyphenols on the Human Intestinal Microbiota: A Review
Nemzer, B. V., Al-Taher, F., Kalita, D., Yashin, A. Y., & Yashin, Y. I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031335 · Cited by 93
Zebrafish Avatars towards Personalized Medicine—A Comparative Review between Avatar Models
Costa, B. F., Estrada, M. F., Mendes, R. V., & Fior, R. (2020) · Cells · doi:10.3390/cells9020293 · Cited by 87
Fidelle, M., Yonekura, S., Picard, M., Cogdill, A. P., Hollebecque, A., Roberti, M. P., & Zitvogel, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.600886 · Cited by 87
Self-citationPhysical activity and cancer risk. Actual knowledge and possible biological mechanisms
Jurdana, M. (2021) · Radiology and Oncology · doi:10.2478/raon-2020-0063 · Cited by 98
Microbiota as a mediator of cancer progression and therapy
Pope, J. L., Tomkovich, S., Yang, Y., & Jobin, C. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.021 · Cited by 80
Miller, P. L., & Carson, T. L. (2020) · Gut Pathogens · doi:10.1186/s13099-020-00381-6 · Cited by 80
Simon, S., Voillet, V., Vignard, V., Wu, Z., Dabrowski, C., Jouand, N., Beauvais, T., Khammari, A., Braudeau, C., Josien, R., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001631 · Cited by 79
Annexin A1: shifting the balance towards resolution and repair
Leoni, G., & Nusrat, A. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0180 · Cited by 78
Routy, B., Letendre, C., Enot, D., Chénard-Poirier, M., Mehraj, V., Séguin, N. C., Guenda, K., Gagnon, K., Woerther, P.-L., Ghez, D., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1258506 · Cited by 75
You, L., Gong, Y., Li, C., Hu, X., Brennan, C. S., & Kulikouskaya, V. I. (2019) · International Journal of Food Science & Technology · doi:10.1111/ijfs.14408 · Cited by 78
Trial watch: immune checkpoint blockers for cancer therapy
Vanpouille-Box, C., Lhuillier, C., Bezu, L., Aranda, F., Yamazaki, T., Kepp, O., Fucikova, J., Spisek, R., Demaria, S., Formenti, S. C., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1373237 · Cited by 73
Self-citationStem cell division theory of cancer
López‐Lázaro, M. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1062330 · Cited by 70
Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
Samanta, S. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621999201210220442 · Cited by 75
Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship
Bodai, B. I., & Nakata, T. E. (2020) · The Permanente Journal · doi:10.7812/tpp/19.129 · Cited by 73
Ilyas, A., Wijayasinghe, Y. S., Khan, I., Samaloty, N. M. E., Adnan, M., Dar, T. A., Poddar, N. K., Singh, L. R., Sharma, H., & Khan, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.964624 · Cited by 73
Han, Z., Chen, Q., Zheng, D., Chen, K., Huang, Q., Zhuang, Z., & Zhang, X. (2023) · Advanced Materials · doi:10.1002/adma.202302551 · Cited by 70
Ponziani, F. R., Nicoletti, A., Gasbarrini, A., & Pompili, M. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919848184 · Cited by 70
Food additive emulsifiers and cancer risk: Results from the French prospective NutriNet-Santé cohort
Sellem, L., Srour, B., Javaux, G., Chazelas, E., Chassaing, B., Viennois, É., Debras, C., Druesne‐Pecollo, N., Esseddik, Y., de Edelenyi, F. S., et al. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004338 · Cited by 72
Moderate-Intensity Physical Exercise Affects the Exercise Performance and Gut Microbiota of Mice
Yang, W., Liu, Y., Yang, G., Meng, B., Yi, Z., Yang, G., Chen, M., Hou, P., Wang, H., & Xu, X. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.712381 · Cited by 67
Metadata
- Authors
- Zitvogel, L., Galluzzi, L., Viaud, S., Vétizou, M., Daillère, R., Merad, M., & Kroemer, G.
- Affiliations
- Inserm (FR)
- Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Corresponding author
- Zitvogel, Laurence
- Galluzzi, Lorenzo
- Venue
- Science Translational Medicine
- Published
- 2015-01-21
- Volume
- 7
- Issue
- 271
- Pages
- 271ps1-271ps1
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC4690201
- OpenAlex
- W2164536401
- Cited by
- 465
- References
- 32
- Citations by year
- 2026: 21 · 2025: 31 · 2024: 35 · 2023: 37 · 2022: 42 · 2021: 62 · 2020: 64 · 2019: 48 · 2018: 46 · 2017: 36 · 2016: 28 · 2015: 15
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Association pour la Recherche sur le Cancer (ARC)
- European Commission (ArtForce)
- European Research Council (ERC)
- Agence Nationale de la Recherche (ANR)
- AXA Chair for Longevity Research
- Fondation pour la Recherche Medicale (FRM)
- Ligue contre le Cancer
- Fondation de France
- Institut National du Cancer (INCa)
- Canceropole Ile-de-France
- Fondation Bettencourt-Schueller
- LabEx Immuno-Oncology
- Site de Recherche Integree sur le Cancer (SIRIC)
- Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE)
- SIRIC Cancer Research and Personalized Medicine (CARPEM)
- Paris Alliance of Cancer Research Institutes (PACRI)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- gut microbiota, cancer, carcinogenesis, tumor progression, host-microbe interactions, intestinal epithelium, host immune system, environmental factors, cancer therapy, microbiome manipulation
- MeSH terms
- Antineoplastic Agents, Humans, Neoplasms, Gastrointestinal Tract, Carcinogenesis, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review